INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,845 Cr | ₹1,665 Cr | ₹1,817 Cr | ₹1,669 Cr | ₹1,541 Cr |
What is the latest Revenue of INDOCO REMEDIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,845 Cr |
| Mar2025 | ₹1,665 Cr |
| Mar2024 | ₹1,817 Cr |
| Mar2023 | ₹1,669 Cr |
| Mar2022 | ₹1,541 Cr |
How is Revenue of INDOCO REMEDIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,845 Cr | 10.84 | |
| Mar2025 | ₹1,665 Cr | -8.38 | |
| Mar2024 | ₹1,817 Cr | 8.91 | |
| Mar2023 | ₹1,669 Cr | 8.30 | |
| Mar2022 | ₹1,541 Cr | - | |
Compare Revenue of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,295.0 Cr | 13.2% | 14.6% | -13.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 13.2% |
14.6% |
-13.1% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses